ArticleStem cell reports2026

Targeting mitotic kinesin KIF20A: A differentiation-based therapeutic strategy for glioblastoma stem/progenitor cells.

Runxiang Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.